Medicines such as GLP-1 receptor agonists can help people with type 2 diabetes lose substantial amounts of weight, but doctors have questioned what that weight loss might mean for aging bones. A large UCLA Health study now offers some reassuring evidence. Instead of seeing more serious fractures, researchers found fewer among patients who started GLP-1 […]

The post Weight-Loss Diabetes Drugs Linked to 21% Lower Risk of Bone Fractures appeared first on Knowridge Science Report.

An oral GLP-1 drug showed promising weight loss results in a phase II trial. A pill-based approach to GLP-1 treatment helped adults with obesity or overweight lose as much as 12 percent of their body weight over 36 weeks, according to a randomized phase II clinical trial published in Nature Medicine. The study tested aleniglipron, [...]